MicroRNAs in cancer - from research to therapy

Biochimica Et Biophysica Acta
William C S Cho

Abstract

MicroRNAs (miRNAs) regulate target gene expression through translation repression or mRNA degradation. These non-coding RNAs are emerging as important modulators in cellular pathways, and they appear to play a key role in tumorigenesis. With increasing understanding of the miRNA target genes and the cellular behaviors influenced by them, modulating the miRNA activities may provide exciting opportunities for cancer therapy. Here the latest findings of which genes are targeted by each miRNA are reviewed, with particular emphasis on the deciphering of their possible mechanisms and the potential of miRNA-based cancer therapeutics.

Citations

Sep 3, 2010·Inflammatory Bowel Diseases·Feng WuJohn H Kwon
Jan 15, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Achim Aigner
Aug 4, 2010·Analytical and Bioanalytical Chemistry·Abraham J QaviRyan C Bailey
Jul 21, 2011·Pharmaceutical Research·Man Lung Yeung, Kuan-Teh Jeang
Nov 11, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seyed H GhaffariKamran Alimoghaddam
Nov 28, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Feng ZhiYilin Yang
Jun 10, 2010·BMC Cancer·Petra LeidingerEckart Meese
Jul 7, 2011·PloS One·Jih-Hsiang LeeGiuseppe Giaccone
Jun 16, 2011·International Journal of Molecular Sciences·De-Cai YuYi-Tao Ding
Feb 9, 2012·International Journal of Molecular Sciences·Ruth ZarateJesús Garcia-Foncillas
Jun 3, 2014·BMC Bioinformatics·Ivani de O N LopesAndré C P de L F de Carvalho
Jan 31, 2014·Neurochemical Research·Feng ZhiYilin Yang
Mar 19, 2013·Clinical Biochemistry·Mariàngels de Planell-Saguer, Maria Celina Rodicio
Apr 4, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X WangZ Gao
May 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shunsuke NoguchiYukihiro Akao
Dec 3, 2014·FEBS Letters·Zhenqiang WangChen Li
Mar 27, 2015·International Journal of Molecular Sciences·Kyvan Dang, Kenneth A Myers
Aug 13, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Hsiang-Lin TsaiJaw-Yuan Wang
Jan 21, 2016·Medicinal Research Reviews·Ashish Ranjan SharmaChiranjib Chakraborty
Feb 22, 2012·The International Journal of Biochemistry & Cell Biology·Lei-lei FuBo Liu
Apr 26, 2011·Mutation Research·Bahaeldin K ElaminMassimo Negrini
Dec 23, 2009·The International Journal of Biochemistry & Cell Biology·William C S Cho
Oct 22, 2016·Cancer Letters·Gaëlle JudesDominique Bernard-Gallon
Oct 1, 2010·IUBMB Life·William C S Cho
Jul 20, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A S AliF H Sarkar
Jul 3, 2013·Journal of Surgical Oncology·Jianguo HeWenyi Xie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.